http://link.springer.com/article/10.1007/s12035-015-9275-2
Abstract
Disturbance
of neuregulin-1β/ErbB4 signaling is considered to be associated with
brain ischemia, but the mechanisms of this disruption are largely
unknown. In the present study, we provide evidence that degradation of
ErbB4 is involved in neuronal cell death in response to ischemia. Our
data showed that the application of neuregulin-1β provided significant
protection against oxygen–glucose deprivation (OGD)-induced neuronal
death as detected by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay, annexin V/propidium iodide flow cytometry analysis and terminal
deoxynucleotidyl transferase (TdT) dUTP nick end labeling (TUNEL)
staining. Furthermore, neuregulin-1β treatment significantly reduced the
infarct volume of ischemic mice, and this result was not seen in the
ErbB4 knockout mice. We found that brain ischemia induced the breakdown
of ErbB4 in a time-dependent manner in vivo, but not that of ErbB2. In
vitro studies further indicated that recombinant calpain induced the
cleavage of ErbB4 in a dose-dependent way, whereas the calpain inhibitor
significantly reduced the OGD-induced ErbB4 breakdown. Additionally,
OGD-induced apoptosis was partially abolished by transfection with the
ErbB4E872K mutant. Taken together, neuregulin-1β elicits its
neuroprotective effect in an ErbB4-dependent manner, and the cleavage of
ErbB4 by calpain contributes to a neuronal cell death cascade during
brain ischemia.
No comments:
Post a Comment